510(k) Predicate Finder
Find potential predicate devices for your 510(k) submission. Enter a K-number to find all clearances with the same product code, a three-letter product code to browse clearances directly, or search by device name.
Next Generation Sequencing Based Tumor Profiling Test
Pathology
The Next Generation Sequencing Based Tumor Profiling Test is a qualitative in vitro diagnostic test intended to detect somatic mutations across a broad panel of targeted genes in tumor specimens from patients diagnosed with malignant solid neoplasms, using targeted next-generation sequencing technology. It is classified as a Class 2 device under regulation 866.6080, requiring 510(k) premarket notification and eligible for third-party review, falling within the Pathology (PA) medical specialty. The product code is PZM. It is not an implant and is not life-sustaining.
510(k) Clearances
8 matchesWhat is a Predicate Device?
A predicate device is a legally marketed device that a new 510(k) applicant uses to demonstrate substantial equivalence. The FDA's 510(k) pathway requires manufacturers to show that their device has the same intended use and similar technological characteristics as one or more predicate devices already cleared for commercial distribution.
Finding the right predicate is a critical step in 510(k) strategy. Manufacturers typically search for cleared devices with the same FDA product code, which groups devices by their intended use and regulatory classification. This tool helps you identify potential predicates by browsing all clearances within a product code.
Note that predicate devices must be legally marketed — they cannot be devices that were cleared but never commercialized, or devices subject to a mandatory recall. The determination of substantial equivalence considers intended use, technological characteristics, and performance data.